Comparison of Fasting Blood Glucose Measurements From Fingertip and Intravenous on Patient Satisfaction in Patients With Diabetes Mellitus

Sponsor
Istanbul University - Cerrahpasa (IUC) (Other)
Overall Status
Recruiting
CT.gov ID
NCT05976191
Collaborator
(none)
110
2
2
7
55
7.9

Study Details

Study Description

Brief Summary

The study was designed as a randomized controlled experimental study in order to compare the fasting blood glucose values measured by puncturing the fingertips and using the intravenous route of patients diagnosed with diabetes mellitus, and to determine the effect on patient satisfaction. The blood glucose measurement via the intravenous catheter has an effect on increasing the comfort of the patient compared to the fingertip measurement. It is thought that information can be provided to increase patient satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Patients whose blood glucose is measured intravenously and from the fingertip
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Crossover Assignment This research was designed in a pretest posttest randomized controlled experimental typeCrossover Assignment This research was designed in a pretest posttest randomized controlled experimental type
Masking:
Single (Participant)
Masking Description:
Single (Participant) Identity information of the patients was concealed and verbal and written consents were obtained.
Primary Purpose:
Supportive Care
Official Title:
Istanbul University Cerrahpaşa-IUC
Actual Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: experimental group

Patients whose blood glucose is measured intravenously and from the fingertip

Behavioral: Patients whose blood glucose is measured intravenously and from the fingertip
A satisfaction survey will be conducted after these patients have previously examined their blood glucose via intravenous route, then fingertip blood glucose will be measured and a satisfaction survey will be applied.

No Intervention: control group

Patients with fingertip blood glucose measurement

Outcome Measures

Primary Outcome Measures

  1. Blood Glucose Measurement Patient Satisfaction Form [four months]

    Does intravenous blood glucose measurement have a positive effect on patient satisfaction compared to fingertip blood glucose measurement?

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years and older

  • No advanced hearing and vision problems

  • Able to speak and understand Turkish

  • Easy to communicate

  • literate

  • Agreeing to participate in the research voluntarily

  • Patients who are hospitalized

  • Regular finger blood sugar monitoring,

  • Patients with an intravenous vascular access date within the first 24 hours

  • Patients who had been diagnosed with Type 2 Diabetes Mellitus for at least one year were.

Exclusion Criteria:
  • Those who are treated with sedative drugs

  • Patients using antipsychotic medication

  • Patients with continuous drug infusion through the intravenous line

  • Patients whose intravenous vascular access date has passed 24 hours

  • Patients in unconscious, confused, apathetic state

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istanbul University-Cerrahpaşa (IUC) Istanbul Şişli Turkey 34381
2 Istanbul University-Cerrahpaşa (IUC) Istanbul Şişli Turkey 34381

Sponsors and Collaborators

  • Istanbul University - Cerrahpasa (IUC)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
AYSEGUL, principal investigator, Istanbul University - Cerrahpasa (IUC)
ClinicalTrials.gov Identifier:
NCT05976191
Other Study ID Numbers:
  • 2022/476
First Posted:
Aug 4, 2023
Last Update Posted:
Aug 4, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by AYSEGUL, principal investigator, Istanbul University - Cerrahpasa (IUC)
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2023